View Financial HealthAtlas Arteria 配当と自社株買い配当金 基準チェック /46Atlas Arteria配当を支払う会社であり、現在の利回りは8.23%です。主要情報8.2%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回り8.2%配当成長9.7%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向224%最近の配当と自社株買いの更新お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.すべての更新を表示Recent updatesお知らせ • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.お知らせ • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026お知らせ • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.お知らせ • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026お知らせ • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.お知らせ • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.お知らせ • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.お知らせ • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.お知らせ • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.お知らせ • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.お知らせ • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024お知らせ • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.お知らせ • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.お知らせ • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023決済の安定と成長配当データの取得安定した配当: MAQA.Fの1株当たり配当金は過去10年間安定しています。増加する配当: MAQA.Fの配当金は過去10年間にわたって増加しています。配当利回り対市場Atlas Arteria 配当利回り対市場MAQA.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (MAQA.F)8.2%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Infrastructure)3.6%アナリスト予想 (MAQA.F) (最長3年)8.2%注目すべき配当: MAQA.Fの配当金 ( 8.23% ) はUS市場の配当金支払者の下位 25% ( 1.41% ) よりも高くなっています。高配当: MAQA.Fの配当金 ( 8.23% ) はUS市場 ( 4.24% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: MAQA.Fは高い 配当性向 ( 223.6% ) のため、配当金の支払いは利益によって十分にカバーされていません。株主配当金キャッシュフローカバレッジ: MAQA.Fは高い 現金配当性向 ( 662.6% ) のため、配当金の支払いはキャッシュフローで十分にカバーされていません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 17:50終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Atlas Arteria Limited 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。15 アナリスト機関Matthew RyanBarrenjoey Markets Pty LimitedShaurya VisenBofA Global ResearchSuraj NebhaniCitigroup Inc12 その他のアナリストを表示
お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.
お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.
お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.
お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.
お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.
お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.
お知らせ • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.
お知らせ • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026
お知らせ • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.
お知らせ • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026
お知らせ • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.
お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.
お知らせ • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.
お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.
お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.
お知らせ • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.
お知らせ • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.
お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.
お知らせ • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.
お知らせ • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.
お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.
お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.
お知らせ • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024
お知らせ • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.
お知らせ • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.
お知らせ • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023